Toxicology Sinks Vernalis PLC, Biogen Idec, Inc. (Massachusetts)'s Parkinson’s Drug

LONDON, July 16 (Reuters) - Vernalis (VER.L) has stopped development of a drug for Parkinson’s disease that represented one of its main pipeline hopes, due to worries over adverse side effects, sending its shares 12 percent lower on Friday.